irasia.com - Investor Relations Asia Pacific
HOME

The United Laboratories International Holdings Limited
(Incorporated in the Cayman Islands with limited liability)

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2015-August-18
  • The United Laboratories International Holdings Limited Announces 2015 Interim Results, Profit from the Core Business Increased by 4.5% to Approximately HK$374.0 Million, Remarkable Sales Performance of Recombinant Human Insulin Injection Products, Steady Growth of Overseas Sales (in PDF)
  • 2015-March-31
  • The United Laboratories International Holdings Limited Announces 2014 Annual Results, Profit Attributable to Equity Holders Significantly Increased by 13.2 Times to HK$681 Million, Selling Prices of Intermediate and Bulk Medicine Products Continuously Increased Satisfactory Sales Performance of the Recombinant Human Insulin Products (in PDF)
  • 2024
  • 2024 Press Releases
  • 2023
  • 2023 Press Releases
  • 2022
  • 2022 Press Releases
  • 2021
  • 2021 Press Releases
  • 2020
  • 2020 Press Releases
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2010
  • 2010 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close